Trial Profile
Comparison of efficacy and safety of insulin detemir in combination with insulin aspart and biphasic insulin aspart 30 [insulin aspart/insulin protamine aspart] in type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin detemir (Primary) ; Insulin aspart/insulin protamine aspart
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms PreFER
- Sponsors Novo Nordisk
- 01 Jul 2009 Actual end date (1 Mar 2005) added as reported by ClinicalTrials.gov.
- 01 Jan 2009 Results have been published in Diabetes, Obesity and Metabolism.
- 01 Jan 2009 Primary endpoint 'Proportion of glycosylated haemoglobin' has been met according to results published in Diabetes, Obesity and Metabolism.